Human medicines European public assessment report (EPAR): Nemdatine, memantine, Alzheimer Disease, Date of authorisation: 22/04/2013, Date of refusal: 22/02/2013, Revision: 8, Status: Authorised

2018 Case Medical Research  
EPAR summary for the public Nemdatine memantine This is a summary of the European public assessment report (EPAR) for Nemdatine. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use.
doi:10.31525/cmr-5871a0 fatcat:e7zvk7cgqfdfle5envwesk5c4e